Lactylation as a metabolic-epigenetic switch in cancer: dual roles in cell death resistance and therapeutic vulnerability

Ge X, Zhang K, Zhu J, Chen Y, Wang Z, Wang P, et al. Targeting protein modification: a new direction for immunotherapy of pancreatic cancer. Int J Biol Sci. 2025;21:63–74.

Google Scholar 

Hsu JM, Li CW, Lai YJ, Hung MC. Posttranslational modifications of PD-L1 and their applications in cancer therapy. Cancer Res. 2018;78:6349–53.

Google Scholar 

Hu Q, Shi Y, Wang H, Bing L, Xu Z. Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy. Exp Hematol Oncol. 2025;14:37.

Google Scholar 

Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575–80.

Google Scholar 

Brooks GA. The science and translation of lactate shuttle theory. Cell Metab. 2018;27:757–85.

Google Scholar 

Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10:38.

Google Scholar 

Ju J, Zhang H, Lin M, Yan Z, An L, Cao Z, et al. The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. J Clin Invest. 2024;134:e174587.

Google Scholar 

Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q, et al. AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature. 2024;634:1229–37.

Google Scholar 

Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang B, et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024;187:2375–92.e33.

Google Scholar 

Zhu R, Ye X, Lu X, Xiao L, Yuan M, Zhao H, et al. ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. Cell Metab. 2025;37:361–76.e7.

Google Scholar 

Liu R, Ren X, Park YE, Feng H, Sheng X, Song X, et al. Nuclear GTPSCS functions as a lactyl-CoA synthetase to promote histone lactylation and gliomagenesis. Cell Metab. 2025;37:377–94.e9.

Google Scholar 

Li X, Zhang C, Mei Y, Zhong W, Fan W, Liu L, et al. Irinotecan alleviates chemoresistance to anthracyclines through the inhibition of AARS1-mediated BLM lactylation and homologous recombination repair. Signal Transduct Target Ther. 2025;10:214.

Google Scholar 

Moreno-Yruela C, Zhang D, Wei W, Baek M, Liu W, Gao J, et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 2022;8:eabi6696.

Google Scholar 

Gonzatti MB, Hintzen JCJ, Sharma I, Najar MA, Tsusaka T, Marcinkiewicz MM, et al. Class I histone deacetylases catalyze lysine lactylation. J Biol Chem. 2025;301:110602.

Google Scholar 

Sun S, Xu Z, He L, Shen Y, Yan Y, Lv X, et al. Metabolic regulation of cytoskeleton functions by HDAC6-catalyzed alpha-tubulin lactylation. Nat Commun. 2024;15:8377.

Google Scholar 

Zhang D, Gao J, Zhu Z, Mao Q, Xu Z, Singh PK, et al. Lysine L-lactylation is the dominant lactylation isomer induced by glycolysis. Nat Chem Biol. 2025;21:91–9.

Google Scholar 

Zhao Q, Wang Q, Yao Q, Yang Z, Li W, Cheng X, et al. Nonenzymatic lysine D-lactylation induced by glyoxalase II substrate SLG dampens inflammatory immune responses. Cell Res. 2025;35:97–116.

Google Scholar 

Jennings EQ, Ray JD, Zerio CJ, Trujillo MN, McDonald DM, Chapman E, et al. Sirtuin 2 regulates protein lactoyllys modifications. Chembiochem. 2021;22:2102–6.

Google Scholar 

Hu X, Huang X, Yang Y, Sun Y, Zhao Y, Zhang Z, et al. Dux activates metabolism-lactylation-MET network during early iPSC reprogramming with Brg1 as the histone lactylation reader. Nucleic Acids Res. 2024;52:5529–48.

Google Scholar 

Zhai G, Niu Z, Jiang Z, Zhao F, Wang S, Chen C, et al. DPF2 reads histone lactylation to drive transcription and tumorigenesis. Proc Natl Acad Sci USA. 2024;121:e2421496121.

Google Scholar 

Nunez R, Sidlowski PFW, Steen EA, Wynia-Smith SL, Sprague DJ, Keyes RF, et al. The TRIM33 bromodomain recognizes histone lysine lactylation. ACS Chem Biol. 2024;19:2418–28.

Google Scholar 

Jin M, Huang B, Yang X, Wang S, Wu J, He Y, et al. Lactylation of XLF promotes non-homologous end-joining repair and chemoresistance in cancer. Mol Cell. 2025;85:2654–72.e7.

Google Scholar 

Chen H, Li Y, Li H, Chen X, Fu H, Mao D, et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631:663–9.

Google Scholar 

Dai C, Tang Y, Yang H, Zheng J. YTHDC1 lactylation regulates its phase separation to enhance target mRNA stability and promote RCC progression. Mol Cell. 2025;85:2733–48.e7.

Google Scholar 

Huang Y, Luo G, Peng K, Song Y, Wang Y, Zhang H, et al. Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity. J Cell Biol. 2024;223:e202308099.

Google Scholar 

Xing Z, Yang T, Li X, Xu H, Hong Y, Shao S, et al. High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy. Cell Rep. 2025;44:115545.

Google Scholar 

Wu W, Zhang J, Sun H, Wu X, Wang H, Cui B, et al. Glycolysis induces abnormal transcription through histone lactylation in T-cell acute lymphoblastic leukemia. Genomics Proteom Bioinforma. 2025;23:qzaf029.

Google Scholar 

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

Google Scholar 

Jin J, Bai L, Wang D, Ding W, Cao Z, Yan P, et al. SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. EMBO Rep. 2023;24:e56052.

Google Scholar 

Li F, Si W, Xia L, Yin D, Wei T, Tao M, et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer. 2024;23:90.

Google Scholar 

Wei S, Zhang J, Zhao R, Shi R, An L, Yu Z, et al. Histone lactylation promotes malignant progression by facilitating USP39 expression to target PI3K/AKT/HIF-1α signal pathway in endometrial carcinoma. Cell Death Discov. 2024;10:121.

Google Scholar 

Zhao R, Yi Y, Liu H, Xu J, Chen S, Wu D, et al. RHOF promotes Snail1 lactylation by enhancing PKM2-mediated glycolysis to induce pancreatic cancer cell endothelial-mesenchymal transition. Cancer Metab. 2024;12:32.

Google Scholar 

Huimin W, Xin W, Shan Y, Junwang Z, Jing W, Yuan W, et al. Lactate promotes the epithelial-mesenchymal transition of liver cancer cells via TWIST1 lactylation. Exp Cell Res. 2025;447:114474.

Google Scholar 

Wu Z, Peng Y, Chen W, Xia F, Song T, Ke Q. Lactylation-driven transcriptional activation of FBXO33 promotes gallbladder cancer metastasis by regulating p53 polyubiquitination. Cell Death Dis. 2025;16:144.

Google Scholar 

Yue Q, Wang Z, Shen Y, Lan Y, Zhong X, Luo X, et al. Histone H3K9 lactylation confers temozolomide resistance in glioblastoma via LUC7L2-mediated MLH1 intron retention. Adv Sci. 2024;11:e2309290.

Google Scholar 

Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, et al. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 2024;73:101059.

Google Scholar 

Lu B, Chen S, Guan X, Chen X, Du Y, Yuan J, et al. Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer. Mol Cancer. 2025;24:83.

Google Scholar 

Sun C, Li X, Teng Q, Liu X, Song L, Schioth HB, et al. Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation. Theranostics. 2025;15:3055–75.

Google Scholar 

Li G, Wang D, Zhai Y, Pan C, Zhang J, Wang C, et al. Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma. Cell Metab. 2024;36:1696–710.e10.

Google Scholar 

Chen Y, Wu J, Zhai L, Zhang T, Yin H, Gao H, et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 2024;187:294–311 e21.

Google Scholar 

Li A, Gong Z, Long Y, Li Y, Liu C, Lu X, et al. Lactylation of LSD1 is an acquired epigenetic vulnerability of BRAFi/MEKi-resistant melanoma. Dev Cell. 2025;60:1974–90.e11.

Google Scholar 

Huang J, Xie H, Li J, Huang X, Cai Y, Yang R, et al. Histone lactylation drives liver cancer metastasis by facilitating NSF1-mediated ferroptosis resistance after microwave ablation. Redox Biol. 2025;81:103553.

Google Scholar 

Zhang K, Guo L, Li X, Hu Y, Luo N. Cancer-associated fibroblasts promote doxorubicin resistance in triple-negative breast cancer through enhancing ZFP64 histone lactylation to regulate ferroptosis. J Transl Med. 2025;23:247.

Google Scholar 

Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, et al. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 2025;16:193.

Google Scholar 

Niu K, Chen Z, Li M, Ma G, Deng Y, Zhang J, et al. NSUN2 lactylation drives cancer cell resistance to ferroptosis through enhancing GCLC-dependent glutathione synthesis. Redox Biol. 2025;79:103479.

Google Scholar 

Chen Y, Yan Q, Ruan S, Cui J, Li Z, Zhang Z, et al. GCLM lactylation mediated by ACAT2 promotes ferroptosis resistance in KRAS(G12D)-mutant cancer. Cell Rep. 2025;44:115774.

Google Scholar 

Yang T, Zhang S, Nie K, Cheng C, Peng X, Huo J, et al. ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion. Drug Resist Updat. 2025;82:101274.

Google Scholar 

Lin J, Yin Y, Cao J, Zhang Y, Chen J, Chen R, et al. NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance. Cell Discov. 2025;11:52.

Google Scholar 

Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, et al. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14:6523.

Google Scholar 

Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20:114–30.

Google Scholar 

Jia M, Yue X, Sun W, Zhou Q, Chang C, Gong W, et al. ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation. Sci Adv. 2023;9:eadg4993.

Google Scholar 

Sun W, Jia M, Feng Y, Cheng X. Lactate is a bridge linking glycolysis and autophagy through lactylation. Autophagy. 2023;19:3240–1.

Google Scholar 

Feng F, Wu J, Chi Q, Wang S, Liu W, Yang L, et al. Lactylome analysis unveils lactylation-dependent mechanisms of stemness remodeling in the liver cancer stem cells. Adv Sci. 2024;11:e2405975.

Google Scholar 

Yan F, Teng Y, Li X, Zhong Y, Li C, Yan F, et al. Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9. Cancer Biol Ther. 2024;25:2304161.

Google Scholar 

Zhou Z, Yin X, Sun H, Lu J, Li Y, Fan Y, et al. PTBP1 lactylation promotes glioma stem cell maintenance through PFKFB4-driven glycolysis. Cancer Res. 2025;85:739–57.

Google Scholar 

He J, Li W, Wang S, Lan J, Hong X, Liao L, et al. Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer. Cancer Lett. 2025;631:217917.

Google Scholar 

Liu Y, Chen J, Ma L, Zhao S, Hui X, Xiong W, et al. ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake. Cell Biol Toxicol. 2025;41:117.

Google Scholar 

Dhimolea E, de Matos Simoes R, Kansara D, Al’Khafaji A, Bouyssou J, Weng X, et al. An embryonic diapause-like adaptation with suppressed Myc activity enables tumor treatment persistence. Cancer Cell. 2021;39:240–56 e11.

Google Scholar 

Sun X, He L, Liu H, Thorne RF, Zeng T, Liu L, et al. The diapause-like colorectal cancer cells induced by SMC4 attenuation are characterized by low proliferation and chemotherapy insensitivity. Cell Metab. 2023;35:1563–79 e8.

Google Scholar 

Huang ZW, Zhang XN, Zhang L, Liu LL, Zhang JW, Sun YX, et al. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct Target Ther. 2023;8:391.

Google Scholar 

Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren H, et al. H3K18 lactylation potentiates immune escape of non-small cell lung cancer. Cancer Res. 2024;84:3589–601.

Google Scholar 

Ding CH, Yan FZ, Xu BN, Qian H, Hong XL, Liu SQ, et al. PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma. Cell Death Dis. 2025;16:158.

Google Scholar 

Tong H, Jiang Z, Song L, Tan K, Yin X, He C, et al. Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation. Cell Metab. 2024;36:2493–510.e9.

Google Scholar 

Li XM, Yang Y, Jiang FQ, Hu G, Wan S, Yan WY, et al. Histone lactylation inhibits RARgamma expression in macrophages to promote colorectal tumorigenesis through activation of TRAF6-IL-6-STAT3 signaling. Cell Rep. 2024;43:113688.

Google Scholar 

Cai J, Song L, Zhang F, Wu S, Zhu G, Zhang P, et al. Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma. Cancer Commun. 2024;44:1231–60.

Google Scholar 

Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, et al. Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell. 2022;82:1660–77 e10.

Google Scholar 

Dang T, You Y, Wei L, Li Q, Sun H, Sun M, et al. ICAT drives lactylation of tumor-associated macrophages via the c-Myc-ENO1 axis to promote cervical cancer progression. Free Radic Biol Med. 2025;241:316–29.

Google Scholar 

Yang J, Yu X, Xiao M, Xu H, Tan Z, Lei Y, et al. Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer. Gut. 2025;74:1859–72.

Google Scholar 

Sun T, Liu B, Li Y, Wu J, Cao Y, Yang S, et al. Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation. J Exp Clin Cancer Res. 2023;42:253.

Google Scholar 

Xue Q, Peng W, Zhang S, Wei X, Ye L, Wang Z, et al. Lactylation-driven TNFR2 expression in regulatory T cells promotes the progression of malignant pleural effusion. J Immunother Cancer. 2024;12:e010040.

Google Scholar 

Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X, et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-beta signaling in regulatory T cells. Cell Rep. 2022;39:110986.

Google Scholar 

Chen J, Zhao D, Wang Y, Liu M, Zhang Y, Feng T, et al. Lactylated apolipoprotein C-II induces immunotherapy resistance by promoting extracellular lipolysis. Adv Sci. 2024;11:e2406333.

Google Scholar 

Ugolini A, De Leo A, Yu X, Scirocchi F, Liu X, Peixoto B, et al. Functional reprogramming of neutrophils within the brain tumor microenvironment by hypoxia-driven histone lactylation. Cancer Discov. 2025;15:1270–96.

Google Scholar 

Wang R, Li C, Cheng Z, Li M, Shi J, Zhang Z, et al. H3K9 lactylation in malignant cells facilitates CD8(+) T cell dysfunction and poor immunotherapy response. Cell Rep. 2024;43:114686.

Google Scholar 

Zhou C, Li W, Liang Z, Wu X, Cheng S, Peng J, et al. Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death. Nat Commun. 2024;15:499.

Google Scholar 

Ma Z, Yang J, Jia W, Li L, Li Y, Hu J, et al. Histone lactylation-driven B7-H3 expression promotes tumor immune evasion. Theranostics. 2025;15:2338–59.

Google Scholar 

Jin J, Yan P, Wang D, Bai L, Liang H, Zhu X, et al. Targeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment. Nat Immunol. 2025;26:1099–112.

Google Scholar 

Luo Y, Yang Z, Yu Y, Zhang P. HIF1alpha lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer. Int J Biol Macromol. 2022;222:2225–43.

Google Scholar 

Han H, Wang S, Ma L, Yin H, Cheng X, Wang Y. ASH2L-K312-Lac stimulates angiogenesis in tumors to expedite the malignant progression of hepatocellular carcinoma. Adv Sci. 2025;12:e09477.

Google Scholar 

Zhao M, Qian Y, He L, Peng T, Wang H, Wang X, et al. Lactate-mediated histone lactylation promotes melanoma angiogenesis via IL-33/ST2 axis. Cell Death Dis. 2025;16:701.

Google Scholar 

Sun K, Zhang X, Shi J, Huang J, Wang S, Li X, et al. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 2025;135:e187024.

Google Scholar 

Cheung SM, Husain E, Masannat Y, Miller ID, Wahle K, Heys SD, et al. Lactate concentration in breast cancer using advanced magnetic resonance spectroscopy. Br J Cancer. 2020;123:261–7.

Google Scholar 

Dutta P, Perez MR, Lee J, Kang Y, Pratt M, Salzillo TC, et al. Combining hyperpolarized real-time metabolic imaging and NMR spectroscopy to identify metabolic biomarkers in pancreatic cancer. J Proteome Res. 2019;18:2826–34.

Google Scholar 

Zhu L, Ruan J, Zhang Q, Feng L, Deng Y, Dai L, et al. LDH and glycolytic activity as predictors of immunotherapy response in gastric cancer: a systematic review and meta-analysis. Front Immunol. 2025;16:1605976.

Google Scholar 

Passardi A, Scarpi E, Tamberi S, Cavanna L, Tassinari D, Fontana A, et al. Impact of pre-treatment lactate dehydrogenase levels on prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer. PLoS One. 2015;10:e0134732.

Google Scholar 

Keilholz U, Martus P, Punt CJ, Kruit W, Mooser G, Schadendorf D, et al. Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-alpha2a (IFNalpha) and interleukin 2 (IL-2) with or without cisplatin. Eur J Cancer. 2002;38:1501–11.

Google Scholar 

Uysal M, Bozcuk H, Sezgin Göksu S, Murat Tatli A, Arslan D, Gündüz S, et al. Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab. Biomed Pharmacother. 2014;68:409–12.

Google Scholar 

Witzig TE, Vukov AM, Habermann TM, Geyer S, Kurtin PJ, Friedenberg WR, et al. Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin’s lymphoma: a phase II trial in the North Central Cancer Treatment Group. J Clin Oncol. 2005;23:1103–8.

Google Scholar 

Gaffney DO, Jennings EQ, Anderson CC, Marentette JO, Shi T, Schou Oxvig AM, et al. Non-enzymatic lysine lactoylation of glycolytic enzymes. Cell Chem Biol. 2020;27:206–13 e6.

Google Scholar 

Trujillo MN, Jennings EQ, Hoffman EA, Zhang H, Phoebe AM, Mastin GE, et al. Lactoylglutathione promotes inflammatory signaling in macrophages through histone lactoylation. Mol Metab. 2024;81:101888.

Google Scholar 

Yang Z, Su W, Zhang Q, Niu L, Feng B, Zhang Y. Lactylation of HDAC1 confers resistance to ferroptosis in colorectal cancer. Adv Sci. 2025;12:e2408845.

Google Scholar 

Duan W, Liu W, Xia S, Zhou Y, Tang M, Xu M, et al. Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis. J Transl Med. 2023;21:547.

Google Scholar 

Cheng S, Chen L, Ying J, Wang Y, Jiang W, Zhang Q, et al. 20(S)-ginsenoside Rh2 ameliorates ATRA resistance in APL by modulating lactylation-driven METTL3. J Ginseng Res. 2024;48:298–309.

Google Scholar 

Lu Y, Zhu J, Zhang Y, Li W, Xiong Y, Fan Y, et al. Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC. Adv Sci. 2024;11:e2401399.

Google Scholar